Gilgamesh Pharmaceuticals, Inc.
Records under this name other than the patents Gilgamesh Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Gilgamesh Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,344,510 | Arylcyclohexylamine Derivatives and Their Use in the Treatment of Psychiatric Disorders now held by Gilgamesh Pharma, Inc. In force · High confidence | In force | High confidence | |
| US 12,534,425 | Phenalkylamines and Methods of Treating Mood Disorders now held by Gilgamesh Pharma, Inc. In force · High confidence | In force | High confidence | |
| 17/404,923 | Methods of Treating Mood Disorders Abandoned Abandoned Jan 13, 2026 | Abandoned | Abandoned Jan 13, 2026 | |
| 17/714,879 | Arylcyclohexylamine Derivatives and Their Use in the Treatment of Psychiatric Disorders now held by Gilgamesh Pharma, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 17/973,119 | Novel Ergolines and Methods of Treating Mood Disorders now held by Gilgamesh Pharma, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/024,545 | Azetidinyl Tryptamines and Methods of Treating Psychiatric Disorders now held by Gilgamesh Pharma, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/281,127 | Phenalkylamines and Methods of Making and Using the Same now held by Gilgamesh Pharma, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/287,980 | Novel Ergolines and Methods of Treating Mood Disorders now held by Gilgamesh Pharma, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/289,476 | Novel Tryptamines and Methods of Treating Mood Disorders now held by Gilgamesh Pharma Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/294,360 | Methods of Treating Neuropsychiatric Disorders now held by Gilgamesh Pharma, Inc. Abandoned Abandoned Oct 28, 2026 | Abandoned | Abandoned Oct 28, 2026 |